FiercePharma4d
Amylyx names chief commercial officer as GLP-1 receptor antagonist launch plans start ramping up
Amylyx Pharmaceuticals has named Dan Monahan as chief commercial officer, positioning an exec who led the U.S.
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer
- Dan Monahan will lead the commercialization strategy across Amylyx’ product portfolio, beginning with avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor ...
Darktrace in first acquisition since takeover as cloud security threats rise
Darktrace has announced its first acquisition since its recent takeover by Thoma Bravo in October, as it focuses on ...
Amylyx appoints Dan Monahan as Chief Commercial Officer
Pharmaceuticals announced the appointment of Dan Monahan as Chief Commercial Officer. Mr. Monahan will also join the Company’s ...
Business Wire4d
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer
Dan Monahan will lead the commercialization strategy across Amylyx’ product portfolio, beginning with avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor ...
Joplin Globe4d
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the appointment of Dan Monahan as Chief Commercial Officer. Mr. Monahan will also join the Company ...